Prelude Capital Management, LLC Co Diagnostics, Inc. Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.76 - $6.29 $64,671 - $108,188	-17,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.03 - $9.61 $86,516 - $165,292	17,200 New	17,200 $106,000
Q3 2020 Nov 16, 2020	SELL	$8.24 - $30.8 $6,592 - $24,640	-800 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.46 - $23.42 $5,968 - $18,736	800 New	800 $15,000

4.51M

3.3K

198K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $41.6M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.